Medite Cancer Diagnostics Inc (MDIT)

[PRVBwealth]

savzak: I agree totally that it is indeed part of a master plan to coincide with the timing of the release of the product. The points I've made are real time effects on the markets viewpoint of CYCR---the stigma of an rs is not one of clever manipulation, but one of desperation and distress. We know the company is not financially distressed, but we also know it doesn't have a product on the market. Incidentally, the realease of a product timed wiith the execution of the rs does not guarantee sales, it just means there is a product on the market waiting for sales. McMahon has got to be there. Earnings per share, and earnings per share only, will drive this thing up. Talk of distribution agreements and partnerships have fluttered around this stock like moths for months. Nobody even bothers trying to net them anymore. The company is out of promise tokens.